# FDA 483 - Robert Clifford, M.D. - August 22, 2018

Source: https://www.globalkeysolutions.net/records/483/robert-clifford-md/6816cd43-2e47-4e77-b7eb-45afa5fd608a

> FDA 483 for Robert Clifford, M.D. on August 22, 2018. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Robert Clifford, M.D.
- Inspection Date: 2018-08-22
- Product Type: drugs
- Office Name: Atlanta District Office
- Summary: An FDA inspection of Robert Clifford, a clinical investigator in Charleston, SC, revealed that a clinical investigation was not conducted in accordance with its investigational plan. Specifically, issues were identified with subject eligibility at enrollment and the non-concurrent completion of subject diary cards. These observations indicate deficiencies in adhering to study protocols and maintaining accurate study records.

## Related Officers

- [investigator](https://www.globalkeysolutions.net/people/eileen-j-bannerman/813432a8-60ce-427f-a0f6-fe6874bc4b59)

Company: https://www.globalkeysolutions.net/companies/robert-clifford-md/c67cddb4-c07b-4417-8d4b-a91576e05559

Office: https://www.globalkeysolutions.net/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7